Shenzhen Chipscreen Biosciences Co., Ltd. 688321.SS Stock
Shenzhen Chipscreen Biosciences Co., Ltd. Price Chart
Shenzhen Chipscreen Biosciences Co., Ltd. 688321.SS Financial and Trading Overview
Contents
- Shenzhen Chipscreen Biosciences Co., Ltd. Price Chart
- Shenzhen Chipscreen Biosciences Co., Ltd. 688321.SS Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of Shenzhen Chipscreen Biosciences Co., Ltd.
- Q&A For Shenzhen Chipscreen Biosciences Co., Ltd. Stock
| Shenzhen Chipscreen Biosciences Co., Ltd. stock price | 20.11 CNY |
| Previous Close | 21.69 CNY |
| Open | 21.73 CNY |
| Bid | 21.73 CNY x N/A |
| Ask | 21.75 CNY x N/A |
| Day's Range | 21.58 - 21.97 CNY |
| 52 Week Range | 20.82 - 32.3 CNY |
| Volume | 1.81M CNY |
| Avg. Volume | 3.67M CNY |
| Market Cap | 8.94B CNY |
| Beta (5Y Monthly) | 0.51221 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0.22 CNY |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
688321.SS Valuation Measures
| Enterprise Value | 8.86B CNY |
| Trailing P/E | N/A |
| Forward P/E | 35.622948 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 16.799826 |
| Price/Book (mrq) | 6.081724 |
| Enterprise Value/Revenue | 16.655 |
| Enterprise Value/EBITDA | 444.632 |
Trading Information
Shenzhen Chipscreen Biosciences Co., Ltd. Stock Price History
| Beta (5Y Monthly) | 0.51221 |
| 52-Week Change | -13.65% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 32.3 CNY |
| 52 Week Low | 20.82 CNY |
| 50-Day Moving Average | 25.19 CNY |
| 200-Day Moving Average | 24.98 CNY |
688321.SS Share Statistics
| Avg. Volume (3 month) | 3.67M CNY |
| Avg. Daily Volume (10-Days) | 2.19M CNY |
| Shares Outstanding | 411.29M |
| Float | 232.33M |
| Short Ratio | N/A |
| % Held by Insiders | 41.28% |
| % Held by Institutions | 6.21% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -2.11% |
| Operating Margin (ttm) | -4.29% |
| Gross Margin | 94.08% |
| EBITDA Margin | 3.74% |
Management Effectiveness
| Return on Assets (ttm) | -0.13% |
| Return on Equity (ttm) | -1.28% |
Income Statement
| Revenue (ttm) | 531.99M CNY |
| Revenue Per Share (ttm) | 1.31 CNY |
| Quarterly Revenue Growth (yoy) | 2.00% |
| Gross Profit (ttm) | 533.46M CNY |
| EBITDA | 19.93M CNY |
| Net Income Avi to Common (ttm) | -11260194 CNY |
| Diluted EPS (ttm) | -0.03 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 776.24M CNY |
| Total Cash Per Share (mrq) | 1.91 CNY |
| Total Debt (mrq) | 838.69M CNY |
| Total Debt/Equity (mrq) | 53.23 CNY |
| Current Ratio (mrq) | 1.958 |
| Book Value Per Share (mrq) | 3.573 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -17077764 CNY |
| Levered Free Cash Flow (ttm) | -306976416 CNY |
Profile of Shenzhen Chipscreen Biosciences Co., Ltd.
| Country | China |
| State | N/A |
| City | Shenzhen |
| Address | Zhigu Industrial Park |
| ZIP | 518057 |
| Phone | 86 755 3699 3500 |
| Website | https://www.chipscreen.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 1045 |
Shenzhen Chipscreen Biosciences Co., Ltd. engages in the research, development, and sale of original small molecule drugs. The company develops precursor compounds and original new drug product lines for the treatment of human diseases in five therapeutic areas, including cancer, metabolic diseases, autoimmune disorders, central nervous system disorders, and antivirals. It is developing chidamide, a subtype-selective benzamide inhibitor of histone deacetylase (HDAC) primarily targeting subtypes 1, 2, 3 of class I HDAC; chiglitazar, a new-generation insulin sensitizing candidate drug for the treatment of type 2 diabetes mellitus; chiauranib, an aurora B/VEGFR/PDGFR /c-Kit/CSF1R inhibitor; and CS12192, a highly selective JAK3 kinase inhibitor. Shenzhen Chipscreen Biosciences Co., Ltd. was founded in 2001 and is headquartered in Shenzhen, China.
Q&A For Shenzhen Chipscreen Biosciences Co., Ltd. Stock
What is a current 688321.SS stock price?
Shenzhen Chipscreen Biosciences Co., Ltd. 688321.SS stock price today per share is 20.11 CNY.
How to purchase Shenzhen Chipscreen Biosciences Co., Ltd. stock?
You can buy 688321.SS shares on the Shanghai exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Shenzhen Chipscreen Biosciences Co., Ltd.?
The stock symbol or ticker of Shenzhen Chipscreen Biosciences Co., Ltd. is 688321.SS.
Which industry does the Shenzhen Chipscreen Biosciences Co., Ltd. company belong to?
The Shenzhen Chipscreen Biosciences Co., Ltd. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Shenzhen Chipscreen Biosciences Co., Ltd. have in circulation?
The max supply of Shenzhen Chipscreen Biosciences Co., Ltd. shares is 411.29M.
What is Shenzhen Chipscreen Biosciences Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Shenzhen Chipscreen Biosciences Co., Ltd. PE Ratio is 91.40909600 now.
What was Shenzhen Chipscreen Biosciences Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Shenzhen Chipscreen Biosciences Co., Ltd. EPS is 0.22 CNY over the trailing 12 months.
Which sector does the Shenzhen Chipscreen Biosciences Co., Ltd. company belong to?
The Shenzhen Chipscreen Biosciences Co., Ltd. sector is Healthcare.